
- /
- Supported exchanges
- / US
- / XAIR.NASDAQ
Beyond Air Inc (XAIR NASDAQ) stock market data APIs
Beyond Air Inc Financial Data Overview
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Beyond Air Inc data using free add-ons & libraries
Get Beyond Air Inc Fundamental Data
Beyond Air Inc Fundamental data includes:
- Net Revenue: 3 705 K
- EBITDA: -41 333 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-17
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Beyond Air Inc News

Beyond Air shareholders approve reverse stock split authorization
Beyond Air, Inc. (NASDAQ:XAIR) announced that shareholders have approved a proposal authorizing the company’s board of directors to implement a reverse stock split of its common stock at a ratio bet...


Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
LungFit PH II’s smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the co...

Earnings week ahead: KR, ACN, ACB, and more
[Calendar with Juneteenth National Independence Day June, 19 date with US flag] LeMusique/iStock via Getty Images With trading paused midweek for the Juneteenth holiday on Thursday, the upcoming earn...

BEYOND AIR Earnings Preview: Recent $XAIR Insider Trading, Hedge Fund Activity, and More
BEYOND AIR ($XAIR) is expected to release its quarterly earnings data on Tuesday, June 17th after market close, per Finnhub. Analysts are expecting revenue of $1,415,964 and earnings of -$0.12 per sha...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.